Overview

Eplerenone for the Treatment of Central Serous Chorioretinopathy

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy .
Phase:
N/A
Details
Lead Sponsor:
Wills Eye
Collaborator:
Mid Atlantic Retina
Treatments:
Eplerenone
Spironolactone